Coeptis Therapeutics Holdings, Inc.
COEP
$8.76
$0.495.93%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 53.85% | 43.18% | 18.27% | 38.11% | 43.40% |
| Total Depreciation and Amortization | 0.28% | 0.17% | 3.43% | 3.44% | 3.45% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -81.94% | -79.32% | -49.72% | -71.04% | -66.12% |
| Change in Net Operating Assets | -107.25% | 1,212.45% | 674.98% | 445.21% | 413.89% |
| Cash from Operations | 8.16% | -8.03% | -27.51% | -62.17% | -86.79% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 171.43% | -- | -- |
| Cash from Investing | -- | -- | 171.43% | -- | -- |
| Total Debt Issued | 184.62% | 300.00% | -126.27% | -- | -- |
| Total Debt Repaid | 46.86% | 68.67% | 16.36% | 30.20% | 49.32% |
| Issuance of Common Stock | -88.66% | -36.42% | -4.67% | -18.92% | -37.88% |
| Repurchase of Common Stock | -- | -71,328.57% | -64,185.71% | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 150.00% | 213.90% | 213.90% | 132.54% | 132.54% |
| Cash from Financing | 16.18% | 1,452.34% | -24.71% | 48.57% | -10.39% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 59.68% | 95.40% | -295.01% | -354.68% | -244.07% |